186 related articles for article (PubMed ID: 37399858)
1. The Diabetes-Heart Disease Connection: Recent Discoveries and Implications.
Suman S; Biswas A; Kohaf N; Singh C; Johns R; Jakkula P; Hastings N
Curr Probl Cardiol; 2023 Nov; 48(11):101923. PubMed ID: 37399858
[TBL] [Abstract][Full Text] [Related]
2. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
Kones R
Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
[TBL] [Abstract][Full Text] [Related]
3. Navigating Cardiovascular Risk in Type 1 Diabetes: A Comprehensive Review of Strategies for Prevention and Management.
Maqusood S; Chakole V; Dash S
Cureus; 2024 May; 16(5):e60426. PubMed ID: 38882982
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus.
Cardoso R; Dudum R; Ferraro RA; Bittencourt M; Blankstein R; Blaha MJ; Nasir K; Rajagopalan S; Michos ED; Blumenthal RS; Cainzos-Achirica M
Circ Cardiovasc Imaging; 2020 Sep; 13(9):e011365. PubMed ID: 32900225
[TBL] [Abstract][Full Text] [Related]
5. A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.
Fisman EZ; Tenenbaum A
Cardiovasc Diabetol; 2009 Jul; 8():38. PubMed ID: 19619327
[TBL] [Abstract][Full Text] [Related]
6. Prediabetes: Why Should We Care?
Zand A; Ibrahim K; Patham B
Methodist Debakey Cardiovasc J; 2018; 14(4):289-297. PubMed ID: 30788015
[TBL] [Abstract][Full Text] [Related]
7. Heart failure and diabetes: Understanding the bidirectional relationship.
Elendu C; Amaechi DC; Elendu TC; Ashna M; Ross-Comptis J; Ansong SO; Egbunu EO; Okafor GC; Jingwa KA; Akintunde AA; Ogah CM; Edeko MO; Ibitoye AV; Ogunseye MO; Alakwe-Ojimba CE; Omeludike EK; Oguine CA; Afuh RN; Olawuni CA; Ekwem OR; Oyedele BA; Pius EI; Asekhauno MO; Ladele JA; Okoro CB; Monika Pouekoua BC; Adenikinju JS; Agu-Ben CM; Aborisade O
Medicine (Baltimore); 2023 Sep; 102(37):e34906. PubMed ID: 37713837
[TBL] [Abstract][Full Text] [Related]
8. [Current status and influencing factors for physicians in different departments prescribing novel hypoglycemic agent with cardiovascular benefits].
Zhou LQ; Zhu D; Xu SL; Zhang RT; Yang LC; Deng XN; Xu L; Dong SJ; Liu W; Wang YT; Liu Y; Xu DX; Zhu YN; Yang J; Tong SM; Tang YD
Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(8):578-584. PubMed ID: 36822869
[No Abstract] [Full Text] [Related]
9. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
Kones R
Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
[TBL] [Abstract][Full Text] [Related]
10. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
Rao S
Adv Ther; 2022 Feb; 39(2):845-861. PubMed ID: 34881413
[TBL] [Abstract][Full Text] [Related]
11. Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
Scheen AJ
Expert Rev Clin Pharmacol; 2023; 16(11):1053-1062. PubMed ID: 37919944
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic management of patients with both heart failure and diabetes.
MacDonald MR; Petrie MC; Fisher M; McMurray JJ
Curr Heart Fail Rep; 2009 Jun; 6(2):126-32. PubMed ID: 19486597
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.
Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; McCoy RG; Mentz RJ; PiÑa IL; ; ;
J Card Fail; 2019 Aug; 25(8):584-619. PubMed ID: 31174952
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes and heart failure : Update 2017].
Schütt K; Marx N
Herz; 2017 May; 42(3):329-340. PubMed ID: 28396903
[TBL] [Abstract][Full Text] [Related]
15. After avandia: the use of antidiabetic drugs in patients with heart failure.
Khalaf KI; Taegtmeyer H
Tex Heart Inst J; 2012; 39(2):174-8. PubMed ID: 22740727
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations for cardiovascular rehabilitation in diabetes mellitus].
Camerini A; Chieffo C; Griffo R; Comaschi M; Gattone M; Mannucci E; Faglia E; Giorda C; Biorci ML; Fattirolli F;
Monaldi Arch Chest Dis; 2003 Dec; 60(4):263-82. PubMed ID: 15061601
[TBL] [Abstract][Full Text] [Related]
18. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
Arnold SV; Bhatt DL; Barsness GW; Beatty AL; Deedwania PC; Inzucchi SE; Kosiborod M; Leiter LA; Lipska KJ; Newman JD; Welty FK;
Circulation; 2020 May; 141(19):e779-e806. PubMed ID: 32279539
[TBL] [Abstract][Full Text] [Related]
19. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
20. Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management.
Luo F; Das A; Chen J; Wu P; Li X; Fang Z
Cardiovasc Diabetol; 2019 Apr; 18(1):54. PubMed ID: 31029144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
